Hips Don’t Lie: J&J Faces Compensation Maelstrom In India Over Faulty ASR Implants

Johnson & Johnson is caught in the eye of a storm in India, after an expert panel recommended compensation for patients affected by its 'faulty' ASR hip implants.  A stinging report by the panel raises several questions around J&J’s alleged “lack of seriousness” in addressing the issue - charges that the company denies - though it remains to be seen how the Indian government ensures that Indian patients get a fair deal.

Stormy
J&J finds itself caught in a storm in India over its ASR hip implants • Source: shutterstock.com

A long-running controversy around compensating patients in India who had been implanted with DePuy’s faulty ASR hip system has come to a boil, with a government constituted expert panel recommending that such patients be duly compensated.

The panel has, among a string of recommendations, set a base compensation of INR2m ($28,280.50) per patient and recommended that Johnson & Johnson's orthopedics company (referred to as DePuy...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Asia

More from Geography